Literature DB >> 19401389

T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible.

Yu-Hwa Huang1, Alla L Zozulya, Christian Weidenfeller, Nicholas Schwab, Heinz Wiendl.   

Abstract

CD4(+) T cells constitutively expressing the immune-tolerogenic HLA-G have been described recently as a new type of nT(reg) (HLA-G(pos) T(reg)) in humans. HLA-G(pos) T(reg) accumulate at sites of inflammation and are potent suppressors of T cell proliferation in vitro, suggesting their role in immune regulation. We here characterize the mechanism of how CD4(+) HLA-G(pos) T(reg) influence autologous HLA-G(neg) T(resp) function. Using a suppression system free of APC, we demonstrate a T-T cell interaction, resulting in suppression of HLA-G(neg) T(resp), which is facilitated by TCR engagement on HLA-G(pos) T(reg). Suppression is independent of cell-cell contact and is reversible, as the removal of HLA-G(pos) T(reg) from the established coculture restored the proliferative capability of responder cells. Further, HLA-G(pos) T(reg)-mediated suppression critically depends on the secretion of IL-10 but not TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401389     DOI: 10.1189/jlb.1008649

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  29 in total

Review 1.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

Review 2.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 3.  CD8(+) Tregs in autoimmunity: learning "self"-control from experience.

Authors:  Sue Tsai; Xavier Clemente-Casares; Pere Santamaria
Journal:  Cell Mol Life Sci       Date:  2011-06-14       Impact factor: 9.261

Review 4.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

5.  HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control.

Authors:  Selena Viganò; Jordi J Negrón; Samantha Tse; Fatema Z Chowdhury; Mathias Lichterfeld; Xu G Yu
Journal:  AIDS       Date:  2017-01-14       Impact factor: 4.177

6.  Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders.

Authors:  Prince Amoah Barnie; Pan Zhang; Hongxiang Lv; Dan Wang; Xiaolian Su; Zhaoliang Su; Huaxi Xu
Journal:  Exp Ther Med       Date:  2016-12-30       Impact factor: 2.447

Review 7.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

Review 8.  The role of HLA-G in immunity and hematopoiesis.

Authors:  Edgardo D Carosella; Silvia Gregori; Nathalie Rouas-Freiss; Joel LeMaoult; Catherine Menier; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

9.  HLA-G, cytokines, and cytokine receptors in the non-aggressive basal cell carcinoma microenvironment.

Authors:  Andrezza Telles Westin; Luiz Gustavo Gardinassi; Edson Garcia Soares; João Santana Da Silva; Eduardo Antonio Donadi; Cacilda Da Silva Souza
Journal:  Arch Dermatol Res       Date:  2021-04-03       Impact factor: 3.017

10.  Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection.

Authors:  Chun Li; Ilona Toth; Julian Schulze Zur Wiesch; Florencia Pereyra; Jennifer Rychert; Eric S Rosenberg; Jan van Lunzen; Mathias Lichterfeld; Xu G Yu
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.